| Mary A Williams, FNP | |
|
125 Highway 322, Clarksdale, MS 38614 | |
| (662) 351-1970 | |
| Not Available |
| Full Name | Mary A Williams |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 13 Years |
| Location | 125 Highway 322, Clarksdale, Mississippi |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184806150 | NPI | - | NPPES |
| 08038821 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | R854909 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sta Home Health And Hospice | Greenwood, MS | Home health agency |
| Northwest Mississippi Medical Center | Clarksdale, MS | Hospital |
| Entity Name | Urgent & Primary Care Of Clarksdale Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013444058 PECOS PAC ID: 4486917721 Enrollment ID: O20180418002842 |
News Archive
New research has shown that many young Australians are not having their wishes to donate their organs honored because they fail to discuss these issues with their families beforehand. As a remedial measure Australia's chief medical officer, Professor Jim Bishop has urged more of the young population to come forth about their wishes to donate their organs after death.
Plexxikon Inc. announces that enrollment has been initiated and the first patient has been dosed in a pivotal Phase 3 trial of PLX4032 (RG7204) in patients with metastatic melanoma. PLX4032 is a novel, oral and highly targeted drug that is designed to inhibit the BRAF cancer-causing mutation that occurs in about 50 percent of melanomas and about eight percent of all solid tumors. The randomized, controlled, Phase 3 "BRAF Inhibitor in Melanoma" (BRIM3) trial in previously untreated patients is part of the planned registration program for PLX4032.
The authors of this study assert that the decisions about which drugs are selected for state Medicaid reimbursement programs "should be based on available evidence and free of conflicts of interests (COIs)."
In an aging society, falling is a growing problem. Just one bad fall can mark the start of a downward spiral in an older person's health and quality of life. The cost of treating falls also puts a heavy burden on the health care system. Toronto Rehab scientists have developed a simple footwear insole called SoleSensor(TM), which has proven to improve balance and prevent falls.
The Robert Wood Johnson Foundation (RWJF) has awarded multi-year grants to 41 communities across the country as part of a landmark national program to reverse the childhood obesity epidemic by 2015.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mary A Williams, FNP 125 Highway 322, Clarksdale, MS 38614-4620 Ph: (662) 351-1970 | Mary A Williams, FNP 125 Highway 322, Clarksdale, MS 38614 Ph: (662) 351-1970 |
News Archive
New research has shown that many young Australians are not having their wishes to donate their organs honored because they fail to discuss these issues with their families beforehand. As a remedial measure Australia's chief medical officer, Professor Jim Bishop has urged more of the young population to come forth about their wishes to donate their organs after death.
Plexxikon Inc. announces that enrollment has been initiated and the first patient has been dosed in a pivotal Phase 3 trial of PLX4032 (RG7204) in patients with metastatic melanoma. PLX4032 is a novel, oral and highly targeted drug that is designed to inhibit the BRAF cancer-causing mutation that occurs in about 50 percent of melanomas and about eight percent of all solid tumors. The randomized, controlled, Phase 3 "BRAF Inhibitor in Melanoma" (BRIM3) trial in previously untreated patients is part of the planned registration program for PLX4032.
The authors of this study assert that the decisions about which drugs are selected for state Medicaid reimbursement programs "should be based on available evidence and free of conflicts of interests (COIs)."
In an aging society, falling is a growing problem. Just one bad fall can mark the start of a downward spiral in an older person's health and quality of life. The cost of treating falls also puts a heavy burden on the health care system. Toronto Rehab scientists have developed a simple footwear insole called SoleSensor(TM), which has proven to improve balance and prevent falls.
The Robert Wood Johnson Foundation (RWJF) has awarded multi-year grants to 41 communities across the country as part of a landmark national program to reverse the childhood obesity epidemic by 2015.
› Verified 7 days ago
Margaret Chandler Lewis, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2245 N State St, Clarksdale, MS 38614 Phone: 662-627-4131 Fax: 662-627-4131 | |
Mrs. Regina Denise Groner, NURSE PRACTITIONER Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 619 S State St, Clarksdale, MS 38614 Phone: 662-966-1012 | |
Gwenevere Chew, CFNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 340 Desoto Avenue Ext, Clarksdale, MS 38614 Phone: 662-741-2151 Fax: 662-741-2700 | |
Anna Jones, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 220 Sunflower Ave, Clarksdale, MS 38614 Phone: 662-351-2035 Fax: 662-351-2045 | |
Lashonda Lashay Bradley, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1967 Hospital Dr, Clarksdale, MS 38614 Phone: 662-624-5481 Fax: 662-621-1499 | |
Dr. Carleen Thompson, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1402 Miller Dr, Clarksdale, MS 38614 Phone: 662-627-8694 | |
Undra L Haggan, NURSE PRACTITIONER Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1202 Desoto Ave, Clarksdale, MS 38614 Phone: 662-202-1297 |